Find your path to Ken
355 people in our graph can introduce you to Ken.
Sign up to see every warm intro you have to Ken
- Paths you didn't know you had: your email and LinkedIn already hold routes to Ken. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Kenneth MacLeod joined Rosetta Capital as a Partner in 2021, bringing over 35 years of life sciences experience across operating roles at healthcare companies (Abbott Labs., Serono) and fund management (SV Health Investors, Paul Capital, Visium Healthcare Partners). He holds board seats at JenaValve Technologies and Oxular, and holds a BSc from the University of Manchester and a D.Phil from the University of York.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Experience
- ROSETTA CAPITAL LIMITEDPartnercurrent2021 — present
- JenaValve Technology, Inc.Non Executive Directorcurrent2023 — presentIrvine, California, United States
- OxularNon Executive Director2023 — 2024Oxford, England, United Kingdom
- Sequana Medical NVNon Executive Director2023 — 2024Ghent, Flemish Region, Belgium
- Agate Strategic Advisors LtdManaging Director2016 — 2021
- Phase III Development Company SARLDirector2009 — 2017Luxembourg
- Visium Asset UK LLP; Visium Healthcare Partners FundManaging Partner2013 — 2016London, United Kingdom & New York, USA
- On-X Life Technologies, IncDirector2012 — 2016Austin, Texas, USA
- Paul Capital Advisors LLCPartner2004 — 2013London, New York & San Francisco
- Paul Capital Advisors (UK) LtdChief Executive Officer2004 — 2013London Area, United Kingdom
- SpePharm Holding BVDirector2008 — 2012The Randstad, Netherlands
- Pharming Group N.V.Director2006 — 2010Leiden, Netherlands
- SV Health InvestorsVenture Partner2001 — 2003London Area, United Kingdom
- SeronoVP Northern Europe1998 — 2001
- Abbott LaboratoriesDivision Director1988 — 1998
Skills & more
+6 more
InvestmentsMergers & AcquisitionsTechnology TransferStrategyCommercializationLife SciencesFrom Ken's professional profile.
Investments
Board seats
JenaValve Technologies, inc.On-X Life Technologies, Inc.Oxular LimitedPharming Group N.V.SpePharm Holding B.V.
Per the firm's website.
Colleagues at Rosetta Capital Ltd.
Frequently asked questions
- Who is Ken MacLeod?
- Kenneth MacLeod joined Rosetta Capital as a Partner in 2021, bringing over 35 years of life sciences experience across operating roles at healthcare companies (Abbott Labs., Serono) and fund management (SV Health Investors, Paul Capital, Visium Healthcare Partners). He holds board seats at JenaValve Technologies and Oxular, and holds a BSc from the University of Manchester and a D.Phil from the University of York.
- Where does Ken MacLeod work?
- Ken MacLeod is Partner at Rosetta Capital Ltd..
- What does Ken MacLeod invest in?
- Ken MacLeod invests in Biotech, Healthtech, Medical Devices.
- What boards does Ken MacLeod sit on?
- Ken MacLeod holds tracked board seats at JenaValve Technologies, inc., On-X Life Technologies, Inc., Oxular Limited, Pharming Group N.V., SpePharm Holding B.V..
- Where did Ken MacLeod go to school?
- Ken MacLeod studied at University of York (DPhil, Biology); The University of Manchester (BSc, Biology); Aston University (Biology).
Same school
Also attended University of York108
+ 102 more
Also attended The University of Manchester363
+ 357 more
Also attended Aston University63
+ 57 more
Shared employers
Also worked at JenaValve Technology, Inc.5
Also worked at Oxular3
Also worked at Sequana Medical NV4
Also worked at Paul Capital Advisors LLC11
+ 5 more
















































